JPS6234036B2 - - Google Patents

Info

Publication number
JPS6234036B2
JPS6234036B2 JP55129816A JP12981680A JPS6234036B2 JP S6234036 B2 JPS6234036 B2 JP S6234036B2 JP 55129816 A JP55129816 A JP 55129816A JP 12981680 A JP12981680 A JP 12981680A JP S6234036 B2 JPS6234036 B2 JP S6234036B2
Authority
JP
Japan
Prior art keywords
acid
hydrouracil
compound
piperidinyl
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55129816A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5753481A (en
Inventor
Chiaki Tashiro
Takeshi Kawakita
Ichiro Horii
Koretake Anami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP55129816A priority Critical patent/JPS5753481A/ja
Priority to EP81107170A priority patent/EP0047990B1/en
Priority to DE8181107170T priority patent/DE3162041D1/de
Priority to ES505549A priority patent/ES505549A0/es
Priority to US06/303,269 priority patent/US4514403A/en
Publication of JPS5753481A publication Critical patent/JPS5753481A/ja
Publication of JPS6234036B2 publication Critical patent/JPS6234036B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP55129816A 1980-09-17 1980-09-17 4-hydrouracil-piperidines Granted JPS5753481A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP55129816A JPS5753481A (en) 1980-09-17 1980-09-17 4-hydrouracil-piperidines
EP81107170A EP0047990B1 (en) 1980-09-17 1981-09-11 Hydrouracil compounds
DE8181107170T DE3162041D1 (en) 1980-09-17 1981-09-11 Hydrouracil compounds
ES505549A ES505549A0 (es) 1980-09-17 1981-09-16 Un metodo para producir un compuesto de hidrouracilo
US06/303,269 US4514403A (en) 1980-09-17 1981-09-17 Hydrouracil compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55129816A JPS5753481A (en) 1980-09-17 1980-09-17 4-hydrouracil-piperidines

Publications (2)

Publication Number Publication Date
JPS5753481A JPS5753481A (en) 1982-03-30
JPS6234036B2 true JPS6234036B2 (en, 2012) 1987-07-24

Family

ID=15018924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55129816A Granted JPS5753481A (en) 1980-09-17 1980-09-17 4-hydrouracil-piperidines

Country Status (5)

Country Link
US (1) US4514403A (en, 2012)
EP (1) EP0047990B1 (en, 2012)
JP (1) JPS5753481A (en, 2012)
DE (1) DE3162041D1 (en, 2012)
ES (1) ES505549A0 (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243017A (ja) * 1984-05-16 1985-12-03 Kyowa Hakko Kogyo Co Ltd 抗けいれん組成物
JPS63104923A (ja) * 1986-10-22 1988-05-10 Yoshitomi Pharmaceut Ind Ltd 抗不安薬
US4816585A (en) * 1987-03-05 1989-03-28 Olin Corporation Tetraalkylpiperidinyl substituted uracil derivatives and their use as ultraviolet light stabilizers
US4904714A (en) * 1987-10-02 1990-02-27 Olin Corporation Synthetic resin composition and its method of use
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2727469A1 (de) * 1977-06-18 1978-12-21 Hoechst Ag Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
JPS5524155A (en) * 1978-08-10 1980-02-21 Yoshitomi Pharmaceut Ind Ltd Piperidine derivative having heterocyclic ring at 4-position

Also Published As

Publication number Publication date
EP0047990B1 (en) 1984-01-25
ES8205219A1 (es) 1982-06-01
EP0047990A1 (en) 1982-03-24
US4514403A (en) 1985-04-30
ES505549A0 (es) 1982-06-01
JPS5753481A (en) 1982-03-30
DE3162041D1 (en) 1984-03-01

Similar Documents

Publication Publication Date Title
PT1830869E (pt) Método de tratamento ou profilaxia
CZ149898A3 (cs) Použití epinastinu pro výrobu farmaceutického prostředku
JP3157924B2 (ja) 治療剤
CA2087104C (en) Neuromuscular blocking agents
US6413987B1 (en) Dermal anesthetic agents
JPS6234036B2 (en, 2012)
RU2199539C2 (ru) Бис-кватернизованные производные аммония, фармацевтическая композиция на их основе
US5834490A (en) Cyclopropyl derivatives, preparation method there-of and applications
US4128555A (en) 3-Phenoxypyridine monosulfate and a method for its production
US3235550A (en) Anal g gesiaxoat t tail intravenous injection
KR100500760B1 (ko) 염산 프로피베린의 제조방법
EP3233825B1 (en) Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
EP0677514A1 (en) New cyclopropyl derivatives, preparation method thereof and applications
CN115894371B (zh) 青藤碱酰胺类衍生物及其制备方法和应用、镇痛药物
US4029800A (en) Neuromuscular blocking agents and antagonists
JPS6350327B2 (en, 2012)
Gusel et al. Effect of tryptophan metabolites on activity of the epileptogenic focus in the frog hippocampus
JP3247763B2 (ja) キサンチン誘導体からなる血液循環の中断による神経損傷の治療用医薬
US4939129A (en) Uses of 4-(3-phosphono-2-propenyl)-2-pierazinecarboxylic acid
WO2016099394A1 (en) Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression.
DE2102831C3 (de) Pyridoxin-Ester, deren Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
Huq Central nervous system mediated cardiovascular responses to drugs.
EP1658847A2 (en) Indane derivatives as dermal anesthetic agents